首页> 外文期刊>American Journal of Health-System Pharmacy >Affirming science and peer-review publishing
【24h】

Affirming science and peer-review publishing

机译:肯定科学和同行评审发表

获取原文
获取原文并翻译 | 示例
       

摘要

The March 15, 2007, issue of AJHP included an article that compared the performance of five devices used in the compounding of sterile products.1 The manufacturer of one of the devices brought suit against ASHP (the publisher of AJHP) and the authors of the paper, claiming that it was defamed through the criticism and test results published in the article. Sworn depositions were required of the Journal's editor in chief and the senior editor, who had managed the submitted manuscript. Among other items of evidence demanded by the plaintiff were the peer reviewers' comments, names, credentials, experience, and all communications between the corresponding editor and the authors. AJHP chose to submit reviewers' comments because they were directly relevant as evidence that AJHP editors had no reason to think that the manuscript included falsities or reckless disregard for the truth. This defamation case was fundamentally different from a recent drug product liability case in which reviewers' comments were successfully withheld from evidence because the court considered them irrelevant to the adverse effects of a specific drug.2 To protect the reviewers, AJHP redacted their comments to remove everything that could reveal their identities before surrendering the reviews as evidence.
机译:AJHP于2007年3月15日发行,其中一篇文章比较了用于配制无菌产品的五种器械的性能。1其中一种器械的制造商提起了ASHP的诉讼(AJHP的发行人)和该出版物的作者。该论文声称,它因文章中的批评和测试结果而受到诽谤。 《华尔街日报》的主编和负责编辑提交稿件的高级编辑均需作宣誓供词。原告要求提供的其他证据包括同行评审的评论,姓名,证书,经验以及相应编辑者与作者之间的所有联系。 AJHP之所以选择提交审稿人的评论,是因为它们与AJHP的编辑直接相关,以证明AJHP的编辑没有理由认为手稿包含虚假事实或对事实的鲁ck无视。此诽谤案与最近的药品责任案根本不同,在最近的药品责任案中,由于法院认为评论与特定药物的不良影响无关,因此成功地拒绝了评论者的评论。2为了保护评论者,AJHP删除了他们的评论,以删除在将评论作为证据之前,所有可能揭示其身份的事物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号